(Q37201680)

18 August 2017

The pharmacokinetics and pharmacodynamics of warfarin in combination with ambrisentan in healthy volunteers (English)

1 reference

18 August 2017

1 reference

1 reference

1 reference

4

Jürgen Venitz

1 reference

18 August 2017

Gennyne Walker

1

1 reference

18 August 2017

Arun Mandagere

series ordinal

2

1 reference

18 August 2017

Christopher Dufton

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

4 February 2009

1 reference

British Journal of Clinical Pharmacology

18 August 2017

1 reference

18 August 2017

67

1 reference

18 August 2017

5

1 reference

18 August 2017

527-534

1 reference

Clinical pharmacology of bosentan, a dual endothelin receptor antagonist

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686069

Treatment of pulmonary arterial hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686069

Sitaxsentan therapy for pulmonary arterial hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686069

Pharmacogenetics of warfarin elimination and its clinical implications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686069

Ambrisentan for pulmonary arterial hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686069

Human P450 metabolism of warfarin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686069

Ambrisentan therapy for pulmonary arterial hypertension

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686069

Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686069

Development and validation of a high-performance liquid chromatographic method for the quantitation of warfarin enantiomers in human plasma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686069

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686069

Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686069

Pulmonary Arterial Hypertension

3 September 2018

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Bosentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Effect of the endothelin-receptor antagonist bosentan on the pharmacokinetics and pharmacodynamics of warfarin

1 reference

12 December 2020

10.1111/J.1365-2125.2009.03384.X

Identifiers

DOI

1 reference

release_4zlxj3f5abgonevksc7sljhphu

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4zlxj3f5abgonevksc7sljhphu

24 November 2022

mapped directly with Wikidata item

1 reference

18 August 2017

PubMed publication ID

19552747

1 reference